U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C26H26N6O3
Molecular Weight 470.523
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of POSELTINIB

SMILES

CN1CCN(CC1)C2=CC=C(NC3=NC4=C(OC=C4)C(OC5=CC(NC(=O)C=C)=CC=C5)=N3)C=C2

InChI

InChIKey=LZMJNVRJMFMYQS-UHFFFAOYSA-N
InChI=1S/C26H26N6O3/c1-3-23(33)27-19-5-4-6-21(17-19)35-25-24-22(11-16-34-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)

HIDE SMILES / InChI

Approval Year

Cmax

ValueDoseCo-administeredAnalytePopulation
11.5 ng/mL
5 mg single, oral
POSELTINIB plasma
Homo sapiens
56.5 ng/mL
30 mg single, oral
POSELTINIB plasma
Homo sapiens
186 ng/mL
80 mg single, oral
POSELTINIB plasma
Homo sapiens
358 ng/mL
160 mg single, oral
POSELTINIB plasma
Homo sapiens
65.8 ng/mL
30 mg 1 times / day steady-state, oral
POSELTINIB plasma
Homo sapiens
201 ng/mL
30 mg 1 times / day multiple, oral
POSELTINIB plasma
Homo sapiens

AUC

ValueDoseCo-administeredAnalytePopulation
84.8 ng × h/mL
5 mg single, oral
POSELTINIB plasma
Homo sapiens
276 ng × h/mL
30 mg single, oral
POSELTINIB plasma
Homo sapiens
1040 ng × h/mL
80 mg single, oral
POSELTINIB plasma
Homo sapiens
2100 ng × h/mL
160 mg single, oral
POSELTINIB plasma
Homo sapiens
368 ng × h/mL
30 mg 1 times / day steady-state, oral
POSELTINIB plasma
Homo sapiens
1347 ng × h/mL
30 mg 1 times / day multiple, oral
POSELTINIB plasma
Homo sapiens

T1/2

ValueDoseCo-administeredAnalytePopulation
5.6 h
30 mg 1 times / day multiple, oral
POSELTINIB plasma
Homo sapiens